UNTIL A FEW weeks ago Asia offered a glimmer of hope in a gloomy global economy. The region seemed to offer a prospect of growth – especially in China – in welcome contrast to stagnation in Europe and the US. Asian companies and their bankers had looked forward to capital raising and making new investments. Then the first reports emerged of a virulent life-threatening illness spreading out from a focus in southern China.
In the wake of growing panic, Euromoney asks a banker what is ostensibly a simple question: what will investors be seeing from Asian corporates in the American depositary receipts market over the rest of the year? But it plainly poses him problems.
Access intelligence that drives action
To unlock this research, enter your email to log in or enquire about access
